CVS Health Co. (NYSE:CVS) Position Raised by Strategic Wealth Partners Ltd.

Strategic Wealth Partners Ltd. raised its stake in CVS Health Co. (NYSE:CVSGet Rating) by 12.3% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 17,553 shares of the pharmacy operator’s stock after buying an additional 1,926 shares during the quarter. Strategic Wealth Partners Ltd.’s holdings in CVS Health were worth $1,777,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently added to or reduced their stakes in CVS. Arlington Partners LLC increased its holdings in shares of CVS Health by 23.4% during the first quarter. Arlington Partners LLC now owns 528 shares of the pharmacy operator’s stock valued at $53,000 after purchasing an additional 100 shares during the period. Wiley BROS. Aintree Capital LLC increased its holdings in shares of CVS Health by 4.6% during the first quarter. Wiley BROS. Aintree Capital LLC now owns 2,265 shares of the pharmacy operator’s stock valued at $229,000 after purchasing an additional 100 shares during the period. Palladium Partners LLC increased its holdings in shares of CVS Health by 2.8% during the first quarter. Palladium Partners LLC now owns 3,687 shares of the pharmacy operator’s stock valued at $373,000 after purchasing an additional 100 shares during the period. Tortoise Investment Management LLC grew its holdings in CVS Health by 6.6% during the first quarter. Tortoise Investment Management LLC now owns 1,612 shares of the pharmacy operator’s stock worth $163,000 after acquiring an additional 100 shares during the period. Finally, Keudell Morrison Wealth Management grew its holdings in CVS Health by 3.2% during the first quarter. Keudell Morrison Wealth Management now owns 3,266 shares of the pharmacy operator’s stock worth $331,000 after acquiring an additional 102 shares during the period. 77.64% of the stock is currently owned by institutional investors.

CVS Health Trading Up 0.6 %

Shares of NYSE CVS opened at $101.05 on Thursday. The stock has a market cap of $132.66 billion, a price-to-earnings ratio of 16.33, a PEG ratio of 1.55 and a beta of 0.73. The business has a 50 day simple moving average of $99.11 and a 200 day simple moving average of $99.39. CVS Health Co. has a 52 week low of $81.78 and a 52 week high of $111.25. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.65 and a current ratio of 0.91.

CVS Health (NYSE:CVSGet Rating) last announced its quarterly earnings results on Wednesday, August 3rd. The pharmacy operator reported $2.40 EPS for the quarter, beating the consensus estimate of $2.16 by $0.24. The business had revenue of $80.64 billion during the quarter, compared to analysts’ expectations of $76.38 billion. CVS Health had a return on equity of 15.19% and a net margin of 2.65%. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.42 EPS. On average, research analysts predict that CVS Health Co. will post 8.54 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, August 1st. Investors of record on Friday, July 22nd were issued a $0.55 dividend. The ex-dividend date of this dividend was Thursday, July 21st. This represents a $2.20 annualized dividend and a yield of 2.18%. CVS Health’s dividend payout ratio (DPR) is currently 35.77%.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on CVS shares. Credit Suisse Group lifted their target price on CVS Health from $113.00 to $117.00 and gave the stock an “outperform” rating in a report on Monday, August 8th. Mizuho lifted their target price on CVS Health from $115.00 to $120.00 and gave the stock a “buy” rating in a report on Monday, August 15th. Evercore ISI lifted their target price on CVS Health from $120.00 to $125.00 and gave the stock an “outperform” rating in a report on Wednesday, September 7th. Tigress Financial lifted their price target on CVS Health from $125.00 to $130.00 in a research note on Wednesday, August 17th. Finally, Sanford C. Bernstein downgraded CVS Health from an “outperform” rating to a “market perform” rating and cut their price objective for the stock from $122.00 to $112.00 in a report on Thursday, May 26th. Four analysts have rated the stock with a hold rating, nineteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $117.59.

Insider Buying and Selling

In related news, EVP Alan Lotvin sold 22,541 shares of the business’s stock in a transaction that occurred on Thursday, August 4th. The stock was sold at an average price of $104.00, for a total value of $2,344,264.00. Following the completion of the sale, the executive vice president now directly owns 109,183 shares in the company, valued at approximately $11,355,032. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, EVP Alan Lotvin sold 22,541 shares of the company’s stock in a transaction that occurred on Thursday, August 4th. The stock was sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the completion of the transaction, the executive vice president now directly owns 109,183 shares in the company, valued at $11,355,032. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Thomas M. Moriarty sold 138,654 shares of the company’s stock in a transaction that occurred on Tuesday, June 28th. The stock was sold at an average price of $95.00, for a total value of $13,172,130.00. Following the transaction, the executive vice president now owns 626,273 shares of the company’s stock, valued at $59,495,935. The disclosure for this sale can be found here. Corporate insiders own 0.69% of the company’s stock.

CVS Health Profile

(Get Rating)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

Read More

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSGet Rating).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.